Analytical Challenges and Solutions for Enabling Nanoformulations and Non-Viral Modalities in Next-Generation Therapeutics

Join a 49-minute keynote presentation exploring cutting-edge analytical approaches for next-generation therapeutics and nanoformulations. Discover how recent breakthroughs in nanomedicine technology, exemplified by mRNA COVID-19 vaccines reaching over 70% of the global population, have created an urgent need for more sophisticated analytical tools. Learn from Dr. Jelle Penders, an experienced researcher and entrepreneur in biomaterials and analytical chemistry, as he examines the current limitations and emerging solutions in analyzing new medicines. Gain insights into novel analytical methods designed to accelerate R&D and enhance quality control of nanoformulations, supporting advancements in cancer treatments and gene therapy. Understand how these innovative approaches aim to bridge the gap between rapidly evolving therapeutic technologies and their analytical requirements. PACE credits are available for registered Labroots members who complete the webinar viewing requirements.